Alex R Rinehart

A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.

Florin Vaida, Diane V Havlir, M. Lederman, 2006, The Journal of infectious diseases.

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy

Michael Ames, Kurt Hertogs, K. Hertogs, 2002, AIDS.